Amgros I/S
Amgros I/S is a Danish regions-owned procurement partnership that runs centralized EU tenders, price negotiations, and supply operations for all public Danish hospitals, delivering approximately 10.9 billion DKK in 2025 savings and now expanding into pharmacy medicine and primary-sector pricing.
- Company typePrivate
- Founded1990
- HeadquartersKöpenhamn, Sweden
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Amgros I/S does
Amgros I/S is a Danish pharmaceutical and hearing-aid procurement partnership, founded in 1990 and wholly owned by the five Danish regions (De danske regioner). Operating from Dampfærgevej 22 in Copenhagen, the organization holds an exclusive mandate to conduct centralized EU tenders, negotiate confidential price agreements, and manage supply logistics for all public Danish hospitals. In 2025, Amgros delivered approximately 10.9 billion DKK in procurement savings to its region owners, with services spanning new-medicine price negotiations, generic drug procurement, sustainability-criteria tenders, and strategic pharmaceutical inventory management. Beyond medicines, Amgros runs the national hearing-aid procurement program, including tendering, allocation, and trading through portals such as HA-handel, Samnet, and Høreklinik Offentlig/Pulje, and has expanded into medical equipment procurement in partnership with Regionernes Fællesindkøb.
The company's operating model is that of a publicly commissioned, non-profit procurement agency rather than a commercial enterprise. Revenue is derived from owner-region funding and service commissions rather than product markups; pricing is set via confidential tenders and multi-year agreements with pharmaceutical and hearing-aid suppliers. Amgros's core technology footprint is a set of dedicated portals — Leverandørportalen for suppliers, RHA-databasen for regional health authority data, and the hearing-aid suite — supported by Horizon Scanning pipeline analytics and emergency supply chain tools. Go-to-market is direct B2G: Amgros negotiates and contracts directly with pharmaceutical manufacturers on behalf of hospitals, with no intermediary distribution layer. Leadership is headed by CEO Flemming Sonne, with a staff in the 51-100 range.
In 2025 Amgros is actively broadening its mandate. It signed its first pharmacy-medicine (apoteksmedicin) price agreement under a new pilot, stood up pricing infrastructure for the Danish primary healthcare sector (Primærsektor), and deepened collaboration with the Danish Medicines Council (Medicinrådet) on alternative and outcomes-based price agreements. It has also embedded record levels of sustainability criteria into hospital tenders and is participating in Nordic pharmaceutical cooperation. These moves extend the centralized-negotiation model beyond hospital pharmaceuticals into retail pharmacy, primary care, and medical devices, while tightening its mandate on environmental and outcomes-based procurement.
Amgros I/S firmographics
Firmographics- Name
- Amgros I/S
- Legal name
- Amgros I/S
- Website
- https://amgros.dk
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Amgros I/S is a Danish regions-owned procurement partnership that runs centralized EU tenders, price negotiations, and supply operations for all public Danish hospitals, delivering approximately 10.9 billion DKK in 2025 savings and now expanding into pharmacy medicine and primary-sector pricing.
- Ownership category
- akta.pro rank
Amgros I/S industry classification
Industry- Product category
- Pharmaceutical Procurement Services
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)
- akta.pro secondary industries
- Public Health Contracts, Procurement & Vendor Management (HLAJALAE), Tender & Public Procurement Pricing (Hospital/Regional/National Tenders) (HLAIAKAJ), Health Supply Chain, Procurement & Access to Medicines (BPADAIAI), Global Health Supply Chain & Procurement Organizations (HLAJAKAL)
Keywords
Where Amgros I/S is headquartered
LocationHeadquarters
- HQ city
- Köpenhamn
- HQ country
- Sweden
- HQ region
- Europe
Offices1 record
Markets served
Amgros I/S business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Pharmaceutical Procurement Services: Amgros operates as a non-profit purchasing organization owned by Danish regions. They negotiate prices and manage EU tenders for pharmaceutical products on behalf of public Danish hospitals. Their value comes from achieving cost savings for their owner regions rather than generating revenue from product sales.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Public tender-based pricing for Danish hospitals |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Amgros I/S product offering
Product offeringCore offering
Amgros I/S organizes and conducts pharmaceutical and hearing aid procurement tenders on behalf of the Danish regions, negotiating prices with pharmaceutical companies and suppliers and managing the supply of medicines and hearing aids to public Danish hospitals and hearing clinics. The company achieved savings of approximately 10.9 billion DKK in 2025 through these collective negotiations and manages procurement operations for new medicines, generic drugs, primary sector medications, and medical equipment.
Product overview
Amgros I/S operates as a pharmaceutical procurement and supply organization for Danish public hospitals. The company provides a unified portfolio of services centered on medicine procurement, price negotiations, and supply chain management. Key offerings include the Horizon Scanning service for monitoring pharmaceutical developments, Prisforhandling og Udbud for price negotiations and tenders, and Indkøb og Forsyning for supply chain operations. Additionally, Amgros manages several specialized portals including RHA-databasen (regional health database), Høreklinik Offentlig and Høreklinik Pulje (hearing aid clinic portals), Samnet (hearing aid coordination), HA-handel (hearing aid trading), and Leverandørportalen (supplier portal). The company also handles medical equipment procurement through collaboration with Regionernes Fællesindkøb.
Differentiator
Problem solved
Functional benefit
Products and services
- Horizon Scanning
Quantifiable outcome
- Achieved savings of approximately 10.9 billion DKK in 2025 through pharmaceutical procurement and tender negotiations
Companies that use Amgros I/S
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles3 records
Amgros I/S technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Amgros I/S partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Danish Regions (Regionerne)coreAmgros is owned by Danish regions and serves as their centralized pharmaceutical procurement organization. The regions are both owners and primary beneficiaries of Amgros's negotiation services and cost savings.
Scale indicators2 records
Recent moves2 records
Expansion highlights6 records
Amgros I/S competitors and assessment
Company assessmentOthers
- Crown Agents: International development company that runs procurement, supply-chain and capacity-building services for governments and donors. Comparable as a public-sector procurement services provider, though operating commercially and across many product categories rather than Denmark-only.
- Management Sciences for Health (MSH): Global health nonprofit that supports pharmaceutical procurement, supply-chain management and pricing negotiations in low- and middle-income countries. Adjacent comparable in its focus on public-sector pharmaceutical procurement best practice and pricing.
Broad incumbents
- Gavi, the Vaccine Alliance: Multilateral procurement organization that pools vaccine demand across low- and middle-income countries. Comparable to Amgros in using pooled public-sector purchasing power and tenders to drive down pharmaceutical prices, but at global rather than national scale.
- NHS Business Services Authority: Arm's-length body of the UK NHS providing central procurement, reimbursement and supply-chain services. Comparable in function as a large public-sector pharmaceutical purchasing and reimbursement administrator, though operating at national rather than regional level.
- The Global Fund to Fight AIDS, Tuberculosis and Malaria: Multilateral public-sector pooled procurement and grant-making organization for medicines and diagnostics. Comparable in its role as a public-sector aggregator that runs tenders and price negotiations to deliver medicines to public health systems.
- UNICEF Supply Division: UN's central procurement hub for vaccines, medicines and medical supplies, supplying public health systems globally. Functionally comparable to Amgros in the tendering, quality assurance and pooled-volume negotiation of pharmaceuticals and medical devices.
Direct peers
- Legemiddelinnkjøpssamarbeidet (LIS): Norway's national pharmaceutical procurement cooperation, run by the regional health authorities. Directly comparable to Amgros in mandate (centralized hospital drug tendering), ownership structure (public regional health entities), and Nordic public-procurement model.
- TLV (Tandvårds- och läkemedelsförmånsverket): Sweden's Dental and Pharmaceutical Benefits Agency, which negotiates prices and decides on reimbursement for medicines. Closely comparable to Amgros in its public-sector role in pharmaceutical pricing and access decisions in a neighboring Nordic market.
- Regionernes Fællesindkøb (RFI): The Danish regions' joint procurement unit, with which Amgros already collaborates on medical equipment tenders. Directly comparable as a regional public-procurement vehicle in Denmark, focused on non-pharma medical devices and supplies.
Regional players
- Sygehusapotekerne (Hospital Pharmacies of Denmark): The Danish regional hospital pharmacy network that physically receives and dispenses the medicines Amgros tenders for. It is the operational counterpart to Amgros within Denmark and a key stakeholder in the same end-to-end supply chain.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Amgros I/S social profiles
Digital presenceAmgros I/S financial estimates
Financial estimateRevenue estimate
Valuation estimate
Amgros I/S leadership team
Management profileNumber of profiles
Profiles1 record
Amgros I/S funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Amgros I/S M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Amgros I/S
What does Amgros I/S do?
Amgros I/S organizes and conducts pharmaceutical and hearing aid procurement tenders on behalf of the Danish regions, negotiating prices with pharmaceutical companies and suppliers and managing the supply of medicines and hearing aids to public Danish hospitals and hearing clinics. The company achieved savings of approximately 10.9 billion DKK in 2025 through these collective negotiations and manages procurement operations for new medicines, generic drugs, primary sector medications, and medical equipment.
Is Amgros I/S a public or private company?
Amgros I/S is a private company. It is classified as state government owned and is currently operating.
When was Amgros I/S founded?
Amgros I/S was founded in 1990. It employs 51 to 100 people.
Where is Amgros I/S based?
Amgros I/S is headquartered in Köpenhamn, Sweden, in the Europe region.
How does Amgros I/S make money?
One revenue line is on record: pharmaceutical Procurement Services.
Who are Amgros I/S's main competitors?
Others on record are Crown Agents and Management Sciences for Health (MSH). Broad incumbents are Gavi, the Vaccine Alliance, NHS Business Services Authority, The Global Fund to Fight AIDS, Tuberculosis and Malaria and UNICEF Supply Division. Direct peers are Legemiddelinnkjøpssamarbeidet (LIS), TLV (Tandvårds- och läkemedelsförmånsverket) and Regionernes Fællesindkøb (RFI). Sygehusapotekerne (Hospital Pharmacies of Denmark) is listed as a regional player.
Does Amgros I/S have an API?
No public API is recorded for Amgros I/S.
What industry is Amgros I/S in?
Amgros I/S's product category is Pharmaceutical Procurement Services. Its primary akta.pro industry code is HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor), with a secondary code of HLAJALAE, Public Health Contracts, Procurement & Vendor Management. Its SIC code is 5122.